Skip to main content
. 2019 May 27;149(7):1133–1139. doi: 10.1093/jn/nxz029

FIGURE 1.

FIGURE 1

Consolidated Standards of Reporting Trials (CONSORT) diagram showing study participation, random assignment, and PP completion for the CUFOX study. Values represent frequency of events. CUFOX, folinic acid/5-fluorouracil/oxaliplatin + 2 g oral curcumin/d; FOLFOX, folinic acid/5-fluorouracil/oxaliplatin; IMP, investigational medicinal product; PP, per protocol.